Phase 1 Trial of MTP-101P for Safety in Colon Resection Patients
A Phase 1 pilot trial is underway to assess the safety and feasibility of MTP-101P in patients undergoing colon resection.
Company
Pharmaceutical intelligence for MTP-101P with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.